Article Information
History
- July 26, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jishu K. Motta, MD1,*,
- Rahila O. Ogunnaike, MD1,
- Rutvik Shah, MD1,
- Stephanie Stroever, PhD, MPH2,
- Harold V. Cedeño, MD1,
- Shyam K. Thapa, MD1,
- John J. Chronakos, MD3,
- Eric J. Jimenez, MD3,
- Joann Petrini, PhD2 and
- Abhijith Hegde, MD3
- 1Department of Medicine, Danbury Hospital, Danbury, CT
- 2Department of Research and Innovation, Danbury Hospital/ Nuvance Health Network, Danbury, CT
- 3Department of Pulmonary and Critical Care, Danbury Hospital, Danbury, CT
- ↵*Corresponding Author
Name: Jishu Kaul Motta, MD, Address: 24 Hospital Avenue, Danbury, CT 06810, Email: jishu.motta{at}nuvancehealth.org, Telephone: 347-832-5741
Posted July 26, 2020.
Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in COVID-19
